Shargian L, Raanani P, Yeshurun M, Gafter-Gvili A, et al. CAR-T cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis. Br J Haematol 2022 Oct 25. doi: 10.1111/bjh.18506.
PMID: 36281746